US Patent Issued to Etubics on July 29 for "Methods and compositions for producing an adenovirus vector for use with multiple vaccinations" (Washington Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,250, issued on July 29, was assigned to Etubics Corp. (Seattle).

"Methods and compositions for producing an adenovirus vector for use with multiple vaccinations" was invented by Joseph P. Balint (Seattle), Frank R. Jones (Seattle) and Richard B. Gayle III (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided."

The patent was filed on March 19, 2024, under Application No. 18/609,152.

*For further information, including images, charts a...